journal article·2022-06-21Open access

Antibacterial Designs for Implantable Medical Devices: Evolutions and Challenges

Huiliang Cao, Shichong Qiao, Hui Qin, Klaus D. Jandt

Abstract

The uses of implantable medical devices are safer and more common since sterilization methods and techniques were established a century ago; however, device-associated infections (DAIs) are still frequent and becoming a leading complication as the number of medical device implantations keeps increasing. This urges the world to develop instructive prevention and treatment strategies for DAIs, boosting the studies on the design of antibacterial surfaces. Every year, studies associated with DAIs yield thousands of publications, which here are categorized into four groups, i.e., antibacterial surfaces with long-term efficacy, cell-selective capability, tailored responsiveness, and immune-instructive actions. These innovations are promising in advancing the solution to DAIs; whereas most of these are normally quite preliminary “proof of concept” studies lacking exact clinical scopes. To help identify the flaws of our current antibacterial designs, clinical features of DAIs are highlighted. These include unpredictable onset, site-specific incidence, and possibly involving multiple and resistant pathogenic strains. The key point we delivered is antibacterial designs should meet the specific requirements of the primary functions defined by the “intended use” of an implantable medical device. This review intends to help comprehend the complex relationship between the device, pathogens, and the host, and figure out future directions for improving the quality of antibacterial designs and promoting clinical translations.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Orthopedic Infections and Treatments · Bacterial biofilms and quorum sensing · Surgical site infection prevention

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Interfacial Electrochemistry and Biomaterials, School of Materials Science and Engineering, East China University of Science and Technology, Shanghai 200237, China

Lab of Low-Dimensional Materials Chemistry, Key Laboratory for Ultrafine Materials of Ministry of Education, East China University of Science & Technology, Shanghai 200237, China

Chair of Materials Science, Otto Schott Institute of Materials Research (OSIM), Friedrich Schiller University Jena, 07743 Jena, Germany

Department of Implant Dentistry, Shanghai Ninth People’s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China

National Clinical Research Center for Oral Diseases, Shanghai 200011, China

Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai 200011, China

Department of Orthopaedics, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai 200233, China

Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, 07743 Jena, Germany

Jena School for Microbial Communication (JSMC), Neugasse 23, 07743 Jena, Germany

Funding

National Natural Science Foundation of China · Natural Science Foundation of Shanghai

References (100+)

Show source-provided references
1. Implant infections: Adhesion, biofilm formation and immune evasion10.1038/s41579-018-0019-y ↗
2. Accelerated bone ingrowth by local delivery of strontium from surface functionalized titanium implants10.1016/j.biomaterials.2013.04.031 ↗
3. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: Calendar year 2009-a World Society of Arrhythmia’s project10.1111/j.1540-8159.2011.03150.x ↗
4. Are physicians aware of which of their patients have indwelling urinary catheters10.1016/S0002-9343(00)00531-3 ↗
5. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 203010.2106/JBJS.17.01617 ↗
6. Projections of primary TKA and THA in Germany from 2016 through 204010.1097/CORR.0000000000001214 ↗
7. Projections for primary hip and knee replacement surgery up to the year 2060: An analysis based on data from the national joint registry for England, Wales, Northern Ireland and the Isle of Man10.1308/rcsann.2021.0206 ↗
8. Emerging infections program healthcare-associated infections and antimicrobial use prevalence survey team. multistate point-prevalence survey of health care-associated infections10.1056/NEJMoa1306801 ↗
9. Dadi, N.C.T., Radochová, B., Vargová, J., and Bujdáková, H. (2021). Impact of healthcare-associated infections connected to medical devices-an update. Microorganisms, 9.10.3390/microorganisms9112332 ↗
10. Increased periprosthetic hip and knee infection projected from 2014 to 2035 in Taiwan10.1016/j.jiph.2020.04.014 ↗
11. Projected economic burden of periprosthetic joint infection of the hip and knee in the United States10.1016/j.arth.2020.12.005 ↗
12. Study on mechanical behavior of Cu-bearing antibacterial titanium alloy implant10.1016/j.jmbbm.2021.104926 ↗
13. Lysozyme amyloid fibril-integrated PEG injectable hydrogel adhesive with improved antiswelling and antibacterial capabilities10.1021/acs.biomac.1c01597 ↗
14. Yuan, Z., Wu, J., Fu, Z., Meng, S., Dai, L., and Cai, K. (2022). Polydopamine-Mediated Interfacial Functionalization of Implants for Accelerating Infected Bone Repair through Light-Activatable Antibiosis and Carbon Monoxide Gas Regulated Macrophage Polarization. Adv. Funct. Mater., 2200374.10.1002/adfm.202200374 ↗
15. Mussel-inspired and bioclickable peptide engineered surface to combat thrombosis and infection10.34133/2022/9780879 ↗
16. Cao, H., Dauben, T.J., Helbing, C., Jia, Z., Zhang, Y., Huang, M., Müller, L., Gu, S., Zhang, X., and Qin, H. (2022). The antimicrobial effect of calcium-doped titanium is activated by fibrinogen adsorption. Mater. Horiz.10.1039/D1MH02009A ↗
17. Formation of a ZnO nanorods-patterned coating with strong bactericidal capability and quantitative evaluation of the contribution of nanorods-derived puncture and ROS-derived killing
18. A multifunctional antibacterial coating on bone implants for osteosarcoma therapy and enhanced osteointegration. A multifunctional antibacterial coating on bone implants for osteosarcoma therapy and enhanced osteointegration10.1016/j.cej.2021.131155 ↗
19. Bioinspired integration of naturally occurring molecules towards universal and smart antibacterial coatings10.1002/adfm.202108749 ↗
20. Li, W., Hua, G., Cai, J., Zhou, Y., Zhou, X., Wang, M., Wang, X., Fu, B., and Ren, L. (2022). Multi-stimulus responsive multilayer coating for treatment of device-associated infections. J. Funct. Biomater., 13.10.3390/jfb13010024 ↗
21. Two types of bacteriophage-modified alginate hydrogels as antibacterial coatings for implants. Two types of bacteriophage-modified alginate hydrogels as antibacterial coatings for implants10.1016/j.jtice.2022.104353 ↗
22. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds10.1097/00004630-199811000-00013 ↗
23. Silver-coated megaprosthesis in prevention and treatment of peri-prosthetic infections: A systematic review and meta-analysis about efficacy and toxicity in primary and revision surgery10.1007/s00590-020-02779-z ↗
24. The use of gentamicin-coated nails in complex open tibia fracture and revision cases: A retrospective analysis of a single centre case series and review of the literature10.1016/j.injury.2015.09.028 ↗
25. Ankle arthroplasty using three generations of metal and ceramic prostheses10.1097/01.blo.0000131246.79993.ec ↗
26. Infection protocols for implants10.1016/j.cpm.2019.06.007 ↗
27. Merola, M., and Affatato, S. (2019). Materials for hip prostheses: A review of wear and loading considerations. Materials, 12.10.3390/ma12030495 ↗
28. Management of periprosthetic joint infection: The more we learn, the less we know10.1016/j.arth.2017.02.023 ↗
29. New materials for hip and knee joint replacement: What’s hip and what’s in kneed?10.1002/jor.24750 ↗
30. The history and development of breast implants10.1308/rcsann.2020.0003 ↗
31. Salmonella infection of breast implant associated with traveler’s diarrhea: A case report10.1016/j.jpra.2018.08.004 ↗
32. Clinical and microbiological characterization of late breast implant infections after reconstructive breast cancer surgery10.1089/sur.2014.146 ↗
33. Editor’s Choice—European Society for Vascular Surgery (ESVS) 2020 Clinical practice guidelines on the management of vascular graft and endograft infections10.1016/j.ejvs.2019.10.016 ↗
34. Cardiovascular implantable device infections10.1007/s11908-011-0187-7 ↗
35. Self-powered cardiovascular electronic devices and systems10.1038/s41569-020-0426-4 ↗
36. Cardiovascular implantable electronic device infection and new insights about correlation between pro-inflammatory markers and heart failure: A systematic literature review and meta-analysis10.3389/fcvm.2021.602275 ↗
37. Cardiac implantable electronic device infections: Presentation, management, and patient outcomes10.1016/j.hrthm.2010.05.016 ↗
38. Cardiac implantable electronic device infection in the cardiac referral center in Thailand: Incidence, microbiology, risk factors, and outcomes10.1002/joa3.12123 ↗
39. Biomaterials in cochlear implants
40. Non-tuberculous mycobacterial cochlear implant infection: An emerging pathogen10.1179/1754762815Y.0000000002 ↗
41. Salvaging cochlear implant after wound infection: Well worth a try10.1080/14670100.2017.1321299 ↗
42. Recurrent cochlear implant infection treated with exteriorization and partial mastoid obliteration10.1179/1754762815Y.0000000010 ↗
43. Case report-Biofilm infection of a cochlear implant10.1179/1754762811Y.0000000025 ↗
44. Biomaterials selection for neuroprosthetics10.1016/j.cobme.2018.05.003 ↗
45. A cupriavidus pauculus infection in a patient with a deep brain stimulation implant
46. Implant site infection and bone flap osteomyelitis associated with the neuropace responsive neurostimulation system10.1016/j.wneu.2015.11.106 ↗
47. Materials for urinary catheters: A review of their history and development in the UK10.1016/j.medengphy.2004.12.013 ↗
48. Catheter-associated urinary tract infections in intensive care units can be reduced by prompting physicians to remove unnecessary catheters10.1086/502329 ↗
49. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update10.1086/675718 ↗
50. Catheter-associated urinary tract infection, clostridioides difficile colitis, central line-associated bloodstream infection, and methicillin-resistant staphylococcus aureus10.1016/j.mcna.2020.02.004 ↗
51. Risk factors for catheter-associated urinary tract infection among hospitalized patients: A systematic review and meta-analysis of observational studies10.1111/jan.13863 ↗
52. Urinary catheter-associated infections10.1016/j.idc.2018.07.002 ↗
53. Biological reactions to cerebrospinal fluid shunt devices: A review of the cellular pathology10.1097/00006123-199802000-00064 ↗
54. Canadian Nosocomial Infection Surveillance Program (2020). Device-associated infections in Canadian acute-care hospitals from 2009 to 2018. Can. Commun. Dis. Rep., 46, 387–397.10.14745/ccdr.v46i1112a05 ↗
55. Shibamura-Fujiogi, M., Ormsby, J., Breibart, M., Warf, B., Priebe, G.P., Soriano, S.G., Sandora, T.J., and Yuki, K. (2021). Risk factors for pediatric surgical site infection following neurosurgical procedures for hydrocephalus: A retrospective single-center cohort study. BMC Anesthesiol., 21.10.1186/s12871-021-01342-5 ↗
56. Role of biofilm in cerebrospinal fluid shunt infections: A study at tertiary neurocare center from South India10.4103/jnrp.jnrp_22_17 ↗
57. UKSR collaborators, Current epidemiology of cerebrospinal fluid shunt surgery in the UK and Ireland (2004–2013)10.1136/jnnp-2018-319927 ↗
58. A review on biomaterials in orthopedic bone plate application
59. Risk factors for infection in fixation of distal tibia fractures10.1016/j.injury.2021.02.085 ↗
60. Dental implants: A review10.1016/j.morpho.2016.02.002 ↗
61. Successful management of early peri-implant infection and bone loss using a multidisciplinary treatment approach10.1902/cap.2017.170014 ↗
62. Infected total ankle arthroplasty: Risk factors and treatment options10.1177/1071100714568869 ↗
63. The role of microbial biofilms in prosthetic joint infections10.3109/17453674.2014.966290 ↗
64. A study of the sources of infection in colonised shunts10.1111/j.1469-8749.1974.tb03443.x ↗
65. Oral bacterial infections: Diagnosis and management10.1016/j.cden.2016.12.003 ↗
66. Skeletal infections: Microbial pathogenesis, immunity and clinical management10.1038/s41579-022-00686-0 ↗
67. Late infection of an alloplastic chin implant masquerading as squamous cell carcinoma10.1016/j.bjps.2011.12.033 ↗
68. Late hematogenous bacterial infections of breast implants: Two case reports of unique bacterial infections10.1097/SAP.0b013e3181f3e387 ↗
69. The pseudomeningocoele that wasn’t: Case report of an adult who presented with a late infection of an implant10.1016/j.bjps.2010.12.011 ↗
70. Delayed implant infection with Cutibacterium acnes (Propionibacterium acnes) 30 years after silicone sheet orbital floor implant10.1080/01676830.2019.1605613 ↗
71. Propionibacterium acnes orbital abscess10.1001/archopht.1990.01070060029012 ↗
72. Breast implant infection with pasteurella canis: First case-report10.1016/j.jpra.2019.07.006 ↗
73. Disease-modifying anti-rheumatic drugs as a risk factor for delayed DBS implant infection10.1016/j.parkreldis.2018.06.007 ↗
74. Nocardia nova infection of tibia tenodesis implant after anterior cruciate ligament reconstruction in an immunocompetent patient
75. Periprosthetic joint infection with listeria monocytogenes: A case report10.2106/JBJS.CC.19.00489 ↗
76. Madden, G.R., Poulter, M.D., Crawford, M.P., Wilson, D.S., and Donowitz, G.R. (2019). Case report: Anaerobiospirillum prosthetic joint infection in a heart transplant recipient. BMC Musculoskelet. Disord., 20.10.1186/s12891-019-2684-z ↗
77. Total knee bartonella henselae infection: An unusual manifestation of cat scratch disease: A case report10.2106/JBJS.CC.19.00081 ↗
78. A glass fiber-reinforced composite—bioactive glass cranioplasty implant: A case study of an early development stage implant removed due to a late infection10.1016/j.jmbbm.2015.10.030 ↗
79. Successful bony integration of a porous tantalum implant despite longlasting and ongoing infection: Histologic workup of an explanted shoulder prosthesis10.1002/jbm.b.34174 ↗
80. Targeting bacterial membrane function: An underexploited mechanism for treating persistent infections10.1038/nrmicro2474 ↗
81. Dowd, S.E., Sun, Y., Secor, P.R., Rhoads, D.D., Wolcott, B.M., James, G.A., and Wolcott, R.D. (2008). Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol., 8.10.1186/1471-2180-8-43 ↗
82. Ryan, K.J., Ahmad, N., Alspaugh, J.A., and Drew, W.L. (2018). Sherris Medical Microbiology, McGraw-Hill Education. [7th ed.].
83. Bacterial growth and motility in sub-micron constrictions10.1073/pnas.0907542106 ↗
84. Morphological changes of Aeromonas hydrophila in response to osmotic stress10.1016/j.micron.2009.01.006 ↗
85. Highly efficient antibacterial surfaces based on bacterial/cell size selective microporous supports10.1021/acsami.7b11337 ↗
86. Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces10.1016/j.actbio.2010.11.005 ↗
87. On a new method of treating compound fracture, abscess, etc.: With observations on the conditions of suppuration10.1016/S0140-6736(02)51192-2 ↗
88. Antibiotic discovery: History, methods and perspectives10.1016/j.ijantimicag.2018.11.010 ↗
89. Antibiotic prophylaxis in orthopaedic surgery: Difficult decisions in an era of evolving antibiotic resistance10.1302/0301-620X.98B8.37359 ↗
90. Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections10.1002/jor.23656 ↗
91. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections10.1038/s41579-020-0420-1 ↗
92. Acute periprosthetic hip joint infection caused by multidrug-resistant acinetobacter baumannii: Is debridement, antibiotics, irrigation, and implant retention a viable treatment option?
93. Simultaneous infection of abandoned leads and newly implanted leadless cardiac pacemaker: Why did this occur?10.1016/j.jccase.2020.09.005 ↗
94. Surgical cure of clarithromycin resistant Mycobacterium chelonae breast implant infection: A case report and review of the literature10.1016/j.jctube.2020.100183 ↗
95. A ghost left behind after transvenous lead extraction: A finding to be feared
96. Conservative multimodal management of osteosynthesis material in surgical wounds with polymicrobial superinfection, including methicillin-resistant Staphylococcus aureus, Clinical case
97. Salvage of an exposed cranial prosthetic implant using a transposition flap with an indwelling antibiotic irrigation system10.7181/acfs.2019.00647 ↗
98. Use of negative pressure wound therapy to treat a cochlear implant infection around the auricle: A case report10.12968/jowc.2020.29.10.568 ↗
99. Methicillin resistant Staphylococcus aureus infective endocarditis presenting as neutrophilic meningoencephalitis10.21037/acr.2019.11.06 ↗
100. Toxic shock syndrome caused by staphylococcal infection after breast implant surgery: A case report and literature review10.1097/SAP.0000000000001868 ↗